go back

Lisocabtagene Maraleucel (Breyanzi) CAR-T Therapy

New Mexico rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $616,595 · 10th–90th $562,341$977,2370%20%40%10th90th$616,595Professionalmedian $562,341 · 10th–90th $562,341$707,9460%50%90th$562,341$0.1$1.0$20.0$500.0$10.0K$200.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$616,595.00
Median
$870,963.59
Typical High
$1,949,844.60
Aetna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$707,945.78
Molina
Setting
Professional
Modifier
Global
Typical Low
$588,843.66
Median
$588,843.66
Typical High
$1,122,018.45
Providence
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$588,843.66
Typical High
$933,254.30
Providence
Setting
Professional
Modifier
Global
Typical Low
$616,595.00
Median
$645,654.23
Typical High
$812,830.52
United
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$933,254.30
United
Setting
Professional
Modifier
Global
Typical Low
$346,736.85
Median
$512,861.38
Typical High
$1,202,264.43